Juvenile Idiopathic Oligoarthritis
Description
Juvenile idiopathic oligoarthritis is a subtype of juvenile idiopathic arthritis (JIA) that affects children younger than 16 years of age and persists for more than six weeks. It most commonly occurs in girls younger than 6 years of age and is frequently associated with uveitis.
Juvenile idiopathic oligoarthritis has two forms:
a) persistent – involvement of no more than four joints throughout the disease course;
b) extended – involvement of more than four joints after the first six months of disease, usually within the first two years after disease onset.
Symptoms
At disease onset, symptoms are often mild. Parents may notice that the child is reluctant to get out of bed in the morning and experiences morning stiffness. The knees and ankles are most commonly affected. These joints are usually mildly painful, have a limited range of motion, and may be swollen and warm. Joint involvement is typically asymmetric.
In approximately 10% of cases, the small joints of the hands or feet are also affected. Involvement of the temporomandibular joint and cervical spine usually develops later than the first six months of the disease. Temporomandibular joint involvement is often unilateral, resulting in facial asymmetry with deviation of the mandible toward the affected side. If the joint is affected at an early age, mandibular growth may be impaired, resulting in micrognathia (“bird face” deformity).
Progressive joint inflammation may lead to erosive joint damage and destruction. Abnormal bone growth may cause the affected limb to become longer than the unaffected limb, leading to muscle atrophy, spinal deformity, and poor posture.
Uveitis associated with juvenile idiopathic oligoarthritis often begins insidiously, without eye pain, redness, or photophobia. Early inflammatory changes are detectable only by slit-lamp examination performed by an ophthalmologist. Uveitis may occur before, simultaneously with, or after the onset of arthritis. Its course is variable; it may resolve spontaneously, remain mild, or progress, increasing the risk of permanent vision loss and blindness.
Diagnosis
There is no specific diagnostic test for juvenile idiopathic oligoarthritis. Blood tests may show elevated inflammatory markers. The presence of antinuclear antibodies (ANA) is associated with an increased risk of developing uveitis.
In addition to laboratory testing, radiographs of the affected joints are obtained to exclude other conditions. Radiographic evidence of growth disturbances may appear after 2–3 months of active arthritis. If only one joint is affected, synovial fluid aspiration and analysis are performed to exclude septic arthritis.
Treatment
Patients should undergo ophthalmologic examination every three months from the time of diagnosis. Early in the disease, if only one joint is involved, intra-articular glucocorticoid injections may be administered. If multiple joints are affected, treatment with nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, naproxen, or tolmetin, is recommended. NSAID therapy is generally continued for approximately six months after disease remission before discontinuation is considered.
In more advanced disease, disease-modifying antirheumatic drugs (DMARDs), such as methotrexate, hydroxychloroquine, or sulfasalazine, may be added to NSAID therapy. Corticosteroids may also be used when indicated. Medication doses may be gradually reduced after one year of sustained remission. If the disease relapses, treatment is resumed using the same therapeutic approach.
If conventional treatment is ineffective, biologic therapy may be considered, as it can improve disease control and long-term outcomes.
Source | Author Doctor Nikas Samuolis, reviewed by Prof. Virginijus Šapoka | Vilnius University | Faculty of Medicine | Head of the Department of Internal Medicine, Family Medicine, and Oncology